The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease
Public ClinicalTrials.gov record NCT00006187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 15-month study with two phases. During the first 12-month phase of this study, patients will be randomly assigned to receive either active study drug or placebo (approximately half of all patients will be on active study drug, the other half on placebo). The second phase is a 3-month randomized withdrawal period. For this phase approximately 10% of the patients will remain on the active drug.
Study identification
- NCT ID
- NCT00006187
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- May 31, 2005
- Completion
- May 31, 2005
- Last update posted
- Dec 10, 2009
Ends 2005
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pivotal Research Centers | Peoria | Arizona | 85381 | — |
| California Clinical Trials | Beverly Hills | California | 90211 | — |
| Pharmacology Research Institute | Los Alamitos | California | 90720 | — |
| Pharmacology Research Institute | Newport Beach | California | 92660 | — |
| Daniel Grosz MD | Northridge | California | 91324 | — |
| Pharmacology Research Institute | Riverside | California | 92506 | — |
| Pacific Research Network | San Diego | California | 92103 | — |
| San Francisco Headache Clinic | San Francisco | California | 94109 | — |
| Yale University, Alzheimer's Disease ResearchUnit | New Haven | Connecticut | 06520-8037 | — |
| New England Center for Headache | Stamford | Connecticut | 06902 | — |
| Baumel-Eisner Neuromedical Institute | Boca Raton | Florida | 33486 | — |
| Baumel-Eisner Neuromedical Institute | Fort Lauderdale | Florida | 33321 | — |
| ICSL Clinical Studies | Fort Myers | Florida | 33907 | — |
| ICSL Clinical Studies | Melbourne | Florida | 32935 | — |
| ICSL Clinical Studies | Sarasota | Florida | 34232 | — |
| ICSL Clinical Studies | St. Petersburg | Florida | 33702 | — |
| Meridien Research | St. Petersburg | Florida | 33710 | — |
| Premiere Research Institute | West Palm Beach | Florida | 33407 | — |
| Palm Beach Neurological Center | West Palm Beach | Florida | 33410 | — |
| Chicago Center for Clinical Research | Chicago | Illinois | 60610 | — |
| ICSL Clinical Studies | South Yarmouth | Massachusetts | 02664 | — |
| Las Vegas Center for Clinical Research | Las Vegas | Nevada | 89146 | — |
| Nathan Klein Institute | Orangeburg | New York | 10962 | — |
| University of Rochester | Rochester | New York | 14620 | — |
| Piedmont Medical Research Associates | Winston-Salem | North Carolina | 27103 | — |
| Pahl Brain Associates, P.C. | Oklahoma City | Oklahoma | 73118 | — |
| Clinical Pharmaceutical Trials | Tulsa | Oklahoma | 74104-5428 | — |
| Pacific NW Clinical Research Center | Portland | Oregon | 97223 | — |
| Institute for Advanced Clinical Research | Elkins Park | Pennsylvania | 19027 | — |
| ICSL Clinical Studies | Philadelphia | Pennsylvania | 19106 | — |
| ICSL Clinical Studies | East Providence | Rhode Island | 02915 | — |
| Pharmacology Research Clinic | Salt Lake City | Utah | 84107 | — |
| Seattle Clinical Research Center | Seattle | Washington | 98104 | — |
| Froedtert Lutheran Memorial Hospital | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00006187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 10, 2009 · Synced Sep 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00006187 live on ClinicalTrials.gov.